157 related articles for article (PubMed ID: 25990962)
1. Parvovirus B19V infection in Israel: prevalence and occurrence of acute infection between 2008 and 2013.
Mor O; Ofir I; Pavel R; Bassal R; Kra-Oz Z; Cohen D; Shohat T; Mendelson E
Epidemiol Infect; 2016 Jan; 144(1):207-14. PubMed ID: 25990962
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and genotypic characterization of Human Parvovirus B19 in children with measles- and rubella-like illness in Iran.
Rezaei F; Sarshari B; Ghavami N; Meysami P; Shadab A; Salimi H; Mokhtari-Azad T
J Med Virol; 2016 Jun; 88(6):947-53. PubMed ID: 26538067
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and genotypic characterization of human parvovirus B19 in children with hemato-oncological disorders in North India.
Jain P; Jain A; Prakash S; Khan DN; Singh DD; Kumar A; Moulik NR; Chandra T
J Med Virol; 2015 Feb; 87(2):303-9. PubMed ID: 25087946
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and Phylogenetic Analysis of Parvovirus (B19V) among Blood Donors with Different Nationalities Residing in Qatar.
Abdelrahman D; Al-Sadeq DW; Smatti MK; Taleb SA; AbuOdeh RO; Al-Absi ES; Al-Thani AA; Coyle PV; Al-Dewik N; Qahtani AAA; Yassine HM; Nasrallah GK
Viruses; 2021 Mar; 13(4):. PubMed ID: 33805034
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of antibodies to primate erythroparvovirus 1 (B19V) in Australia.
Faddy HM; Gorman EC; Hoad VC; Frentiu FD; Tozer S; Flower RLP
BMC Infect Dis; 2018 Dec; 18(1):631. PubMed ID: 30526514
[TBL] [Abstract][Full Text] [Related]
6. Parvovirus B19 seroprevalence, viral load, and genotype characterization in volunteer blood donors from southern Brazil.
Slavov SN; Rodrigues ES; Sauvage V; Caro V; Diefenbach CF; Zimmermann AM; Covas DT; Laperche S; Kashima S
J Med Virol; 2019 Jul; 91(7):1224-1231. PubMed ID: 30851123
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of parvovirus B19 antibodies in pregnant women in northern Benin.
De Paschale M; Ceriani C; Cerulli T; Cagnin D; Cavallari S; Zaongo D; Diombo K; Priuli G; Viganò P; Finazzi S; Clerici P
Trop Med Int Health; 2023 Mar; 28(3):226-231. PubMed ID: 36647788
[TBL] [Abstract][Full Text] [Related]
8. The seroprevalence of parvovirus B19 infection in pregnant women in Sudan.
Adam O; Makkawi T; Reber U; Kirberg H; Eis-Hübinger AM
Epidemiol Infect; 2015 Jan; 143(2):242-8. PubMed ID: 24650427
[TBL] [Abstract][Full Text] [Related]
9. Genotype 3b of human parvovirus B19 detected from hospitalized children with solid malignancies in a North Indian tertiary care hospital.
Jain A; Jain P; Prakash S; Kumar A; Khan DN; Seth A; Gupta S; Kant R
J Med Virol; 2016 Nov; 88(11):1922-9. PubMed ID: 27116539
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and association of human parvovirus B19V with hepatitis B and C viruses in Nigeria.
Opaleye OO; Fagbami AH; Lalremruata A; Kun JF
J Med Virol; 2011 Apr; 83(4):710-6. PubMed ID: 21328387
[TBL] [Abstract][Full Text] [Related]
11. Human parvovirus B19 and low hemoglobin levels in pregnant Sudanese women.
Gasim GI; Eltayeb R; Elhassan EM; Haggaz AD; Rayis DA; Adam I
Int J Gynaecol Obstet; 2016 Mar; 132(3):318-20. PubMed ID: 26674318
[TBL] [Abstract][Full Text] [Related]
12. The Chemokine CXCL-10 Is a Marker of Infection Stage in Individuals With DNAemia Due to Parvovirus B19.
Weseslindtner L; Aberle JH; Hedman L; Hedman K
J Infect Dis; 2017 Jan; 215(2):214-220. PubMed ID: 27789725
[TBL] [Abstract][Full Text] [Related]
13. Identification of past and recent parvovirus B19 infection in immunocompetent individuals by quantitative PCR and enzyme immunoassays: a dual-laboratory study.
Maple PA; Hedman L; Dhanilall P; Kantola K; Nurmi V; Söderlund-Venermo M; Brown KE; Hedman K
J Clin Microbiol; 2014 Mar; 52(3):947-56. PubMed ID: 24403307
[TBL] [Abstract][Full Text] [Related]
14. Investigation of the prevalence of human parvovirus B19 DNA in Korean plasmapheresis donors.
Oh DJ; Lee YL; Kang JW; Kwon SY; Cho NS
Korean J Lab Med; 2010 Feb; 30(1):58-64. PubMed ID: 20197724
[TBL] [Abstract][Full Text] [Related]
15. Molecular and phylogenetic analyses of human Parvovirus B19 isolated from Brazilian patients with sickle cell disease and β-thalassemia major and healthy blood donors.
Slavov SN; Haddad SK; Silva-Pinto AC; Amarilla AA; Alfonso HL; Aquino VH; Covas DT
J Med Virol; 2012 Oct; 84(10):1652-65. PubMed ID: 22930515
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of parvovirus B19 antibodies among young pregnant women or planning pregnancy, tested for toxoplasmosis.
Zajkowska A; Garkowski A; Czupryna P; Moniuszko A; Król ME; Szamatowicz J; Pancewicz S
Przegl Epidemiol; 2015; 69(3):479-82, 597-600. PubMed ID: 26519843
[TBL] [Abstract][Full Text] [Related]
17. Low-level DNAemia of parvovirus B19 (genotypes 1-3) in adult transplant recipients is not associated with anaemia.
Plentz A; Würdinger M; Kudlich M; Modrow S
J Clin Virol; 2013 Oct; 58(2):443-8. PubMed ID: 23916377
[TBL] [Abstract][Full Text] [Related]
18. High incidence of maternal parvovirus B19 infection in a large unselected population-based pregnancy cohort in Norway.
Barlinn R; Rollag H; Trogstad L; Vainio K; Basset C; Magnus P; Dudman SG
J Clin Virol; 2017 Sep; 94():57-62. PubMed ID: 28759773
[TBL] [Abstract][Full Text] [Related]
19. Persistence of Parvovirus B19 (B19V) DNA and humoral immune response in B19V-infected blood donors.
Juhl D; Görg S; Hennig H
Vox Sang; 2014 Oct; 107(3):226-32. PubMed ID: 24916600
[TBL] [Abstract][Full Text] [Related]
20. Parvovirus B19 Seroprevalence in Women with Bad Obstetric History in Kirkuk.
Alsamarai AM; Hassan HM; Alsamarai MA; Aljumaili ZK
Antiinflamm Antiallergy Agents Med Chem; 2021; 20(4):359-366. PubMed ID: 34315400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
